.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Cipla
US Department of Justice
Cerilliant
Citi
Accenture
Medtronic
Federal Trade Commission
Farmers Insurance
Argus Health

Generated: September 26, 2017

DrugPatentWatch Database Preview

Alcon Pharms Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for ALCON PHARMS LTD, and when can generic versions of ALCON PHARMS LTD drugs launch?

ALCON PHARMS LTD has fifteen approved drugs.

There is one US patent protecting ALCON PHARMS LTD drugs.

There are eighteen patent family members on ALCON PHARMS LTD drugs in sixteen countries.

Summary for Applicant: Alcon Pharms Ltd

Patents:1
Tradenames:14
Ingredients:14
NDAs:15
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alcon Pharms Ltd
GENTAMICIN SULFATE
gentamicin sulfate
SOLUTION/DROPS;OPHTHALMIC062523-001Nov 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
SULFACETAMIDE SODIUM
sulfacetamide sodium
SOLUTION/DROPS;OPHTHALMIC089068-001May 5, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
TRAVATAN
travoprost
SOLUTION/DROPS;OPHTHALMIC021257-001Mar 16, 2001DISCNYesNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE
dexamethasone; neomycin sulfate; polymyxin b sulfate
SUSPENSION/DROPS;OPHTHALMIC062721-001Nov 17, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
KETOTIFEN FUMARATE
ketotifen fumarate
SOLUTION/DROPS;OPHTHALMIC077200-001Sep 2, 2008OTCNoYes► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
PREDNISOLONE SODIUM PHOSPHATE
prednisolone sodium phosphate
SOLUTION/DROPS;OPHTHALMIC081044-001Oct 24, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
TROPICAMIDE
tropicamide
SOLUTION/DROPS;OPHTHALMIC089172-001Dec 28, 1990DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
TOBRAMYCIN
tobramycin
SOLUTION/DROPS;OPHTHALMIC063176-001May 25, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
BETAXON
levobetaxolol hydrochloride
SUSPENSION/DROPS;OPHTHALMIC021114-001Feb 23, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
Alcon Pharms Ltd
BETADINE
povidone-iodine
SOLUTION/DROPS;OPHTHALMIC018634-001Dec 17, 1986RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Alcon Pharms Ltd

Paragraph IV activity for ALCON PHARMS LTD drugs

Drugname Dosage Strength Tradename Submissiondate
travoprost
Ophthalmic Solution0.00%
TRAVATAN
11/28/2008

International Patent Family for Alcon Pharms Ltd Drugs

Country Document Number Estimated Expiration
Japan2008308503► Subscribe
Brazil0116353► Subscribe
Denmark1343474► Subscribe
European Patent Office1343474► Subscribe
South Korea20030063441► Subscribe
Austria459337► Subscribe
TaiwanI290050► Subscribe
World Intellectual Property Organization (WIPO)0249614► Subscribe
Australia3960102► Subscribe
Spain2339745► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Alcon Pharms Ltd Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1920764/01Switzerland► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NUMBER/DATE: SWISSMEDIC 55910 22.05.2002
2008006Lithuania► SubscribePRODUCT NAME: FOSAMPRENAVIR CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001-002 20040712
00540Netherlands► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001-002 20011127
0722Netherlands► SubscribePRODUCT NAME: TOBRAMYCINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: C(2011)5394 20110720
C0045France► SubscribePRODUCT NAME: TRAVOPROST; REGISTRATION NO/DATE: EU/1/01/199/001 20011127
/2015Austria► SubscribePRODUCT NAME: PHENYLEPHRIN, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON, UND KETOROLAC, ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1018 (MITTEILUNG) 20150730
2012017Lithuania► SubscribePRODUCT NAME: TRAVOPROSTUM; NAT. REGISTRATION NO/DATE: LT 02/7821/3 20020402; FIRST REGISTRATION: EU/1/01/199/001 - EU/1/01/199/002 20011127
C/GB03/033United Kingdom► SubscribePRODUCT NAME: ROSUVASTATIN OPTIONALLY IN THE FORM OF A NON-TOXIC PHARMACEUTICALLY ACCEPTABLE SALT, PARTICULARLY THE CALCIUM SALT.; REGISTERED: NL 26872 20021106; NL 26873 20021106; NL 26874 20021106; UK PL 17901/0201 20030321; UK PL 17901/0202 20030321; UK PL 17901/0203 20030321
1273292/01Switzerland► SubscribePRODUCT NAME: TOBRAMYCIN; REGISTRATION NO/DATE: SWISSMEDIC 58751 28.05.2009
00125Netherlands► SubscribePRODUCT NAME: ROSUVASTATINUM, DESGEWENST IN DE VORM VAN EEN NIET-TOXISCH FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER HET CALCIUMZOUT; REGISTRATION NO/DATE: RVG 26872 - RVG 26874 20021106
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Cerilliant
Johnson and Johnson
Express Scripts
Novartis
AstraZeneca
Medtronic
McKesson
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot